BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Park E, Min H, Chung H, Hong J, Kang Y, Hung TM, Youn UJ, Kim YS, Bae K, Kang SS, Lee SK. Down-regulation of c-Src/EGFR-mediated signaling activation is involved in the honokiol-induced cell cycle arrest and apoptosis in MDA-MB-231 human breast cancer cells. Cancer Letters 2009;277:133-40. [DOI: 10.1016/j.canlet.2008.11.029] [Cited by in Crossref: 79] [Cited by in F6Publishing: 81] [Article Influence: 6.1] [Reference Citation Analysis]
Number Citing Articles
1 Khatoon F, Ali S, Kumar V, Elasbali AM, Alhassan HH, Alharethi SH, Islam A, Hassan MI. Pharmacological features, health benefits and clinical implications of honokiol. Journal of Biomolecular Structure and Dynamics. [DOI: 10.1080/07391102.2022.2120541] [Reference Citation Analysis]
2 Jeon SK, Park SM, Ahn JY, Kim OH, Kim YW, Park K, Park S, Lee J. Anticancer activity of herbal formula Jisilhaebaekgyeji-Tang against human breast cancer cells and its mechanism. Mol Cell Toxicol 2022. [DOI: 10.1007/s13273-022-00271-9] [Reference Citation Analysis]
3 Skolastika S, Hanif N, Ikawati M, Hermawan A. Comprehensive Computational Analysis of Honokiol Targets for Cell Cycle Inhibition and Immunotherapy in Metastatic Breast Cancer Stem Cells. Evidence-Based Complementary and Alternative Medicine 2022;2022:1-18. [DOI: 10.1155/2022/4172531] [Reference Citation Analysis]
4 Islam MR, Islam F, Nafady MH, Akter M, Mitra S, Das R, Urmee H, Shohag S, Akter A, Chidambaram K, Alhumaydhi FA, Emran TB, Cavalu S. Natural Small Molecules in Breast Cancer Treatment: Understandings from a Therapeutic Viewpoint. Molecules 2022;27:2165. [PMID: 35408561 DOI: 10.3390/molecules27072165] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 24.0] [Reference Citation Analysis]
5 Lu Q, Lai Y, Zhang H, Ren K, Liu W, An Y, Yao J, Fan H. Hesperetin Inhibits TGF-β1-Induced Migration and Invasion of Triple Negative Breast Cancer MDA-MB-231 Cells via Suppressing Fyn/Paxillin/RhoA Pathway. Integr Cancer Ther 2022;21:15347354221086900. [PMID: 35297710 DOI: 10.1177/15347354221086900] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Zhao W, Liu J, Li Y, Chen Z, Qi D, Zhang Z. Immune Effect of Active Components of Traditional Chinese Medicine on Triple-Negative Breast Cancer. Front Pharmacol 2021;12:731741. [PMID: 34925002 DOI: 10.3389/fphar.2021.731741] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Balogun TA, Ige OM, Alausa AO, Onyeani CO, Tiamiyu ZA, Omoboyowa DA, Saibu OA, Abdullateef OT. Receptor tyrosine kinases as a therapeutic target by natural compounds in cancer treatment. Futur J Pharm Sci 2021;7:197. [DOI: 10.1186/s43094-021-00346-9] [Reference Citation Analysis]
8 Yu C, Long Z, Qiu Q, Liu F, Xu Y, Zhang T, Guo R, Zhong W, Huang S, Chen S. Graphene quantum dots‐based targeted nanoprobes detecting drug delivery, imaging, and enhanced chemotherapy of nasopharyngeal carcinoma. Bioeng Transl Med. [DOI: 10.1002/btm2.10270] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
9 Qi M, Chen X, Bian L, Zhang H, Ma J. Honokiol combined with curcumin sensitizes multidrug-resistant human lung adenocarcinoma A549/DDP cells to cisplatin. Exp Ther Med 2021;22:1301. [PMID: 34630656 DOI: 10.3892/etm.2021.10736] [Reference Citation Analysis]
10 Chen C, Zhang QW, Ye Y, Lin LG. Honokiol: A naturally occurring lignan with pleiotropic bioactivities. Chin J Nat Med 2021;19:481-90. [PMID: 34247771 DOI: 10.1016/S1875-5364(21)60047-X] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
11 Yang J, Zhang X, Liu L, Yang X, Qian Q, Du B. c-Src promotes the growth and tumorigenesis of hepatocellular carcinoma via the Hippo signaling pathway. Life Sci 2021;264:118711. [PMID: 33186566 DOI: 10.1016/j.lfs.2020.118711] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
12 Muniraj N, Siddharth S, Shriver M, Nagalingam A, Parida S, Woo J, Elsey J, Gabrielson K, Gabrielson E, Arbiser JL, Saxena NK, Sharma D. Induction of STK11-dependent cytoprotective autophagy in breast cancer cells upon honokiol treatment. Cell Death Discov 2020;6:81. [PMID: 32963809 DOI: 10.1038/s41420-020-00315-w] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
13 Shen J, Li L, Howlett NG, Cohen PS, Sun G. Application of a Biphasic Mathematical Model of Cancer Cell Drug Response for Formulating Potent and Synergistic Targeted Drug Combinations to Triple Negative Breast Cancer Cells. Cancers (Basel) 2020;12:E1087. [PMID: 32349331 DOI: 10.3390/cancers12051087] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Noel B, Singh SK, Lillard JW Jr, Singh R. Role of natural compounds in preventing and treating breast cancer. Front Biosci (Schol Ed) 2020;12:137-60. [PMID: 32114452 DOI: 10.2741/S544] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
15 Bach D, Kim D, Lee SK. Cancer Chemopreventive Potential of Epidermal Growth Factor Receptor Inhibitors from Natural Products. Natural Products for Cancer Chemoprevention 2020. [DOI: 10.1007/978-3-030-39855-2_14] [Reference Citation Analysis]
16 Ong CP, Lee WL, Tang YQ, Yap WH. Honokiol: A Review of Its Anticancer Potential and Mechanisms. Cancers (Basel) 2019;12:E48. [PMID: 31877856 DOI: 10.3390/cancers12010048] [Cited by in Crossref: 64] [Cited by in F6Publishing: 67] [Article Influence: 21.3] [Reference Citation Analysis]
17 Zhang Y, Liu M, Wang J, Huang J, Guo M, Zuo L, Xu B, Cao S, Lin X. Targeting Protein Kinase Inhibitors with Traditional Chinese Medicine. CDT 2019;20:1505-16. [DOI: 10.2174/1389450120666190802125959] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
18 Khalid S, Khan A, Shal B, Ali H, Kim YS, Khan S. Suppression of TRPV1 and P2Y nociceptors by honokiol isolated from Magnolia officinalis in 3rd degree burn mice by inhibiting inflammatory mediators. Biomedicine & Pharmacotherapy 2019;114:108777. [DOI: 10.1016/j.biopha.2019.108777] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 8.7] [Reference Citation Analysis]
19 Banik K, Ranaware AM, Deshpande V, Nalawade SP, Padmavathi G, Bordoloi D, Sailo BL, Shanmugam MK, Fan L, Arfuso F, Sethi G, Kunnumakkara AB. Honokiol for cancer therapeutics: A traditional medicine that can modulate multiple oncogenic targets. Pharmacological Research 2019;144:192-209. [DOI: 10.1016/j.phrs.2019.04.004] [Cited by in Crossref: 93] [Cited by in F6Publishing: 87] [Article Influence: 31.0] [Reference Citation Analysis]
20 Lee JS, Sul JY, Park JB, Lee MS, Cha EY, Ko YB. Honokiol induces apoptosis and suppresses migration and invasion of ovarian carcinoma cells via AMPK/mTOR signaling pathway. Int J Mol Med 2019;43:1969-78. [PMID: 30864681 DOI: 10.3892/ijmm.2019.4122] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
21 Zhu J, Xu S, Gao W, Feng J, Zhao G. Honokiol induces endoplasmic reticulum stress-mediated apoptosis in human lung cancer cells. Life Sciences 2019;221:204-11. [DOI: 10.1016/j.lfs.2019.01.046] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
22 Razak NA, Abu N, Ho WY, Zamberi NR, Tan SW, Alitheen NB, Long K, Yeap SK. Cytotoxicity of eupatorin in MCF-7 and MDA-MB-231 human breast cancer cells via cell cycle arrest, anti-angiogenesis and induction of apoptosis. Sci Rep 2019;9:1514. [PMID: 30728391 DOI: 10.1038/s41598-018-37796-w] [Cited by in Crossref: 65] [Cited by in F6Publishing: 72] [Article Influence: 21.7] [Reference Citation Analysis]
23 Nasrollahi F, Koh YR, Chen P, Varshosaz J, Khodadadi AA, Lim S. Targeting graphene quantum dots to epidermal growth factor receptor for delivery of cisplatin and cellular imaging. Materials Science and Engineering: C 2019;94:247-57. [DOI: 10.1016/j.msec.2018.09.020] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 14.0] [Reference Citation Analysis]
24 Avtanski D, Poretsky L. Phyto-polyphenols as potential inhibitors of breast cancer metastasis. Mol Med 2018;24:29. [PMID: 30134816 DOI: 10.1186/s10020-018-0032-7] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 10.3] [Reference Citation Analysis]
25 Dai X, Li RZ, Jiang ZB, Wei CL, Luo LX, Yao XJ, Li GP, Leung EL. Honokiol Inhibits Proliferation, Invasion and Induces Apoptosis Through Targeting Lyn Kinase in Human Lung Adenocarcinoma Cells. Front Pharmacol 2018;9:558. [PMID: 29892225 DOI: 10.3389/fphar.2018.00558] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
26 Khalid S, Ullah MZ, Khan AU, Afridi R, Rasheed H, Khan A, Ali H, Kim YS, Khan S. Antihyperalgesic Properties of Honokiol in Inflammatory Pain Models by Targeting of NF-κB and Nrf2 Signaling. Front Pharmacol 2018;9:140. [PMID: 29615898 DOI: 10.3389/fphar.2018.00140] [Cited by in Crossref: 57] [Cited by in F6Publishing: 59] [Article Influence: 14.3] [Reference Citation Analysis]
27 Yang J, Pei H, Luo H, Fu A, Yang H, Hu J, Zhao C, Chai L, Chen X, Shao X, Wang C, Wu W, Wan L, Ye H, Qiu Q, Peng A, Wei Y, Yang L, Chen L. Non-toxic dose of liposomal honokiol suppresses metastasis of hepatocellular carcinoma through destabilizing EGFR and inhibiting the downstream pathways. Oncotarget 2017;8:915-32. [PMID: 27906672 DOI: 10.18632/oncotarget.13687] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
28 Song JM, Anandharaj A, Upadhyaya P, Kirtane AR, Kim JH, Hong KH, Panyam J, Kassie F. Honokiol suppresses lung tumorigenesis by targeting EGFR and its downstream effectors. Oncotarget 2016;7:57752-69. [PMID: 27458163 DOI: 10.18632/oncotarget.10759] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
29 Huang KJ, Kuo CH, Chen SH, Lin CY, Lee YR. Honokiol inhibits in vitro and in vivo growth of oral squamous cell carcinoma through induction of apoptosis, cell cycle arrest and autophagy. J Cell Mol Med 2018;22:1894-908. [PMID: 29363886 DOI: 10.1111/jcmm.13474] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 8.5] [Reference Citation Analysis]
30 Wang T, Chen W, Wu J. H2-P, a honokiol derivative, exerts anti-angiogenesis effects via c-MYC signaling pathway in glioblastoma. J Cell Biochem 2018;119:3142-8. [PMID: 29080353 DOI: 10.1002/jcb.26462] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
31 Yang B, Ni X, Chen L, Zhang H, Ren P, Feng Y, Chen Y, Fu S, Wu J. Honokiol-loaded polymeric nanoparticles: an active targeting drug delivery system for the treatment of nasopharyngeal carcinoma. Drug Deliv 2017;24:660-9. [PMID: 28368206 DOI: 10.1080/10717544.2017.1303854] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
32 Yan L, Miller J, Yuan M, Liu JF, Busch TM, Tsourkas A, Cheng Z. Improved Photodynamic Therapy Efficacy of Protoporphyrin IX-Loaded Polymeric Micelles Using Erlotinib Pretreatment. Biomacromolecules 2017;18:1836-44. [PMID: 28437090 DOI: 10.1021/acs.biomac.7b00274] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 6.4] [Reference Citation Analysis]
33 Lu CH, Chen SH, Chang YS, Liu YW, Wu JY, Lim YP, Yu HI, Lee YR. Honokiol, a potential therapeutic agent, induces cell cycle arrest and program cell death in vitro and in vivo in human thyroid cancer cells. Pharmacol Res. 2017;115:288-298. [PMID: 27940017 DOI: 10.1016/j.phrs.2016.11.038] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 6.3] [Reference Citation Analysis]
34 Pan J, Lee Y, Zhang Q, Xiong D, Wan TC, Wang Y, You M. Honokiol Decreases Lung Cancer Metastasis through Inhibition of the STAT3 Signaling Pathway. Cancer Prev Res (Phila) 2017;10:133-41. [PMID: 27849557 DOI: 10.1158/1940-6207.CAPR-16-0129] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 5.2] [Reference Citation Analysis]
35 Wang B, Zhang J, Song F, Tian M, Shi B, Jiang H, Xu W, Wang H, Zhou M, Pan X, Gu J, Yang S, Jiang L, Li Z. EGFR regulates iron homeostasis to promote cancer growth through redistribution of transferrin receptor 1. Cancer Letters 2016;381:331-40. [DOI: 10.1016/j.canlet.2016.08.006] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 6.5] [Reference Citation Analysis]
36 Kiyama R. Biological effects induced by estrogenic activity of lignans. Trends in Food Science & Technology 2016;54:186-96. [DOI: 10.1016/j.tifs.2016.06.007] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 5.0] [Reference Citation Analysis]
37 Lai YH, Chen MH, Lin SY, Lin SY, Wong YH, Yu SL, Chen HW, Yang CH, Chang GC, Chen JJ. Rhodomycin A, a novel Src-targeted compound, can suppress lung cancer cell progression via modulating Src-related pathways. Oncotarget 2015;6:26252-65. [PMID: 26312766 DOI: 10.18632/oncotarget.4761] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
38 Hahm ER, Singh KB, Singh SV. c-Myc is a novel target of cell cycle arrest by honokiol in prostate cancer cells. Cell Cycle 2016;15:2309-20. [PMID: 27341160 DOI: 10.1080/15384101.2016.1201253] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
39 Thulasiraman P, Johnson AB. Regulation of Mucin 1 and multidrug resistance protein 1 by honokiol enhances the efficacy of doxorubicin-mediated growth suppression in mammary carcinoma cells. Int J Oncol 2016;49:479-86. [PMID: 27221150 DOI: 10.3892/ijo.2016.3534] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
40 Park E, Sang-ngern M, Chang LC, Pezzuto JM. Induction of cell cycle arrest and apoptosis with downregulation of Hsp90 client proteins and histone modification by 4β-hydroxywithanolide E isolated from Physalis peruviana. Mol Nutr Food Res 2016;60:1482-500. [DOI: 10.1002/mnfr.201500977] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
41 Pan J, Lee Y, Wang Y, You M. Honokiol targets mitochondria to halt cancer progression and metastasis. Mol Nutr Food Res 2016;60:1383-95. [DOI: 10.1002/mnfr.201501007] [Cited by in Crossref: 33] [Cited by in F6Publishing: 38] [Article Influence: 5.5] [Reference Citation Analysis]
42 Huang JS, Yao CJ, Chuang SE, Yeh CT, Lee LM, Chen RM, Chao WJ, Whang-Peng J, Lai GM. Honokiol inhibits sphere formation and xenograft growth of oral cancer side population cells accompanied with JAK/STAT signaling pathway suppression and apoptosis induction. BMC Cancer 2016;16:245. [PMID: 27012679 DOI: 10.1186/s12885-016-2265-6] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 5.7] [Reference Citation Analysis]
43 Lin CJ, Chang YA, Lin YL, Liu SH, Chang CK, Chen RM. Preclinical effects of honokiol on treating glioblastoma multiforme via G1 phase arrest and cell apoptosis. Phytomedicine. 2016;23:517-527. [PMID: 27064011 DOI: 10.1016/j.phymed.2016.02.021] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 4.7] [Reference Citation Analysis]
44 Liou S, Hua K, Hsu C, Weng M. Honokiol from Magnolia spp. induces G1 arrest via disruption of EGFR stability through repressing HDAC6 deacetylated Hsp90 function in lung cancer cells. Journal of Functional Foods 2015;15:84-96. [DOI: 10.1016/j.jff.2015.03.018] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
45 Kaushik G, Venugopal A, Ramamoorthy P, Standing D, Subramaniam D, Umar S, Jensen RA, Anant S, Mammen JM. Honokiol inhibits melanoma stem cells by targeting notch signaling. Mol Carcinog 2015;54:1710-21. [PMID: 25491779 DOI: 10.1002/mc.22242] [Cited by in Crossref: 52] [Cited by in F6Publishing: 54] [Article Influence: 6.5] [Reference Citation Analysis]
46 Buecheler JW, Howard CB, de Bakker CJ, Goodall S, Jones ML, Win T, Peng T, Tan CH, Chopra A, Mahler SM, Lim S. Development of a protein nanoparticle platform for targeting EGFR expressing cancer cells. J Chem Technol Biotechnol 2015;90:1230-6. [DOI: 10.1002/jctb.4545] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
47 Fan S, Li X, Lin J, Chen S, Shan J, Qi G. Honokiol inhibits tumor necrosis factor-α-stimulated rat aortic smooth muscle cell proliferation via caspase- and mitochondrial-dependent apoptosis. Inflammation 2014;37:17-26. [PMID: 23933846 DOI: 10.1007/s10753-013-9707-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
48 Saeed M, Kuete V, Kadioglu O, Börtzler J, Khalid H, Greten HJ, Efferth T. Cytotoxicity of the bisphenolic honokiol from Magnolia officinalis against multiple drug-resistant tumor cells as determined by pharmacogenomics and molecular docking. Phytomedicine 2014;21:1525-33. [DOI: 10.1016/j.phymed.2014.07.011] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
49 Hahm ER, Sakao K, Singh SV. Honokiol activates reactive oxygen species-mediated cytoprotective autophagy in human prostate cancer cells. Prostate 2014;74:1209-21. [PMID: 25043291 DOI: 10.1002/pros.22837] [Cited by in Crossref: 53] [Cited by in F6Publishing: 55] [Article Influence: 6.6] [Reference Citation Analysis]
50 Wang H, Liao Z, Sun X, Shi Q, Huo G, Xie Y, Tang X, Zhi X, Tang Z. Intravenous administration of Honokiol provides neuroprotection and improves functional recovery after traumatic brain injury through cell cycle inhibition. Neuropharmacology 2014;86:9-21. [PMID: 24973706 DOI: 10.1016/j.neuropharm.2014.06.018] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
51 Wang X, Beitler JJ, Wang H, Lee MJ, Huang W, Koenig L, Nannapaneni S, Amin AR, Bonner M, Shin HJ, Chen ZG, Arbiser JL, Shin DM. Honokiol enhances paclitaxel efficacy in multi-drug resistant human cancer model through the induction of apoptosis. PLoS One 2014;9:e86369. [PMID: 24586249 DOI: 10.1371/journal.pone.0086369] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
52 Parsyan A, Gonzalez-angulo AM, Zardavas D, Piccart M, Meterissian S. Breast Cancer. Translation and Its Regulation in Cancer Biology and Medicine 2014. [DOI: 10.1007/978-94-017-9078-9_26] [Reference Citation Analysis]
53 Averett C, Arora S, Zubair H, Singh S, Bhardwaj A, Singh AP. Molecular Targets of Honokiol: A Promising Phytochemical for Effective Cancer Management. Enzymes 2014;36:175-93. [PMID: 27102704 DOI: 10.1016/B978-0-12-802215-3.00009-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
54 Kumar A, Kumar Singh U, Chaudhary A. Honokiol analogs: a novel class of anticancer agents targeting cell signaling pathways and other bioactivities. Future Med Chem 2013;5:809-29. [PMID: 23651094 DOI: 10.4155/fmc.13.32] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 4.0] [Reference Citation Analysis]
55 Hua H, Chen W, Shen L, Sheng Q, Teng L. Honokiol augments the anti-cancer effects of oxaliplatin in colon cancer cells. Acta Biochim Biophys Sin (Shanghai) 2013;45:773-9. [PMID: 23786838 DOI: 10.1093/abbs/gmt071] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
56 Kong F, Binas B, Moon JH, Kang SS, Kim HJ. Differential expression of adenylate kinase 4 in the context of disparate stress response strategies of HEK293 and HepG2 cells. Archives of Biochemistry and Biophysics 2013;533:11-7. [DOI: 10.1016/j.abb.2013.02.014] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
57 Dong JX, Zhao GY, Yu QL, Li R, Yuan L, Chen J, Liu Y. Mitochondrial dysfunction induced by honokiol. J Membr Biol 2013;246:375-81. [PMID: 23595822 DOI: 10.1007/s00232-013-9543-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
58 Singh T, Katiyar SK. Honokiol inhibits non-small cell lung cancer cell migration by targeting PGE₂-mediated activation of β-catenin signaling. PLoS One 2013;8:e60749. [PMID: 23580348 DOI: 10.1371/journal.pone.0060749] [Cited by in Crossref: 57] [Cited by in F6Publishing: 64] [Article Influence: 6.3] [Reference Citation Analysis]
59 Park EJ, Chung HJ, Park HJ, Kim GD, Ahn YH, Lee SK. Suppression of Src/ERK and GSK-3/β-catenin signaling by pinosylvin inhibits the growth of human colorectal cancer cells. Food Chem Toxicol 2013;55:424-33. [PMID: 23333577 DOI: 10.1016/j.fct.2013.01.007] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 4.2] [Reference Citation Analysis]
60 Singh T, Prasad R, Katiyar SK. Inhibition of class I histone deacetylases in non-small cell lung cancer by honokiol leads to suppression of cancer cell growth and induction of cell death in vitro and in vivo. Epigenetics 2013;8:54-65. [PMID: 23221619 DOI: 10.4161/epi.23078] [Cited by in Crossref: 46] [Cited by in F6Publishing: 53] [Article Influence: 4.6] [Reference Citation Analysis]
61 Simpson NE, Tryndyak VP, Pogribna M, Beland FA, Pogribny IP. Modifying metabolically sensitive histone marks by inhibiting glutamine metabolism affects gene expression and alters cancer cell phenotype. Epigenetics. 2012;7:1413-1420. [PMID: 23117580 DOI: 10.4161/epi.22713] [Cited by in Crossref: 53] [Cited by in F6Publishing: 57] [Article Influence: 5.3] [Reference Citation Analysis]
62 Cheng Z. Comparative studies on the interactions of honokiol and magnolol with human serum albumin. Journal of Pharmaceutical and Biomedical Analysis 2012;66:240-51. [DOI: 10.1016/j.jpba.2012.03.010] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 2.8] [Reference Citation Analysis]
63 Ling C, Chen G, Chen G, Zhang Z, Cao B, Han K, Yin J, Chu A, Zhao Y, Mao X. A deuterated analog of dasatinib disrupts cell cycle progression and displays anti-non-small cell lung cancer activity in vitro and in vivo. Int J Cancer 2012;131:2411-9. [PMID: 22362357 DOI: 10.1002/ijc.27504] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
64 Nagalingam A, Arbiser JL, Bonner MY, Saxena NK, Sharma D. Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis. Breast Cancer Res 2012;14:R35. [PMID: 22353783 DOI: 10.1186/bcr3128] [Cited by in Crossref: 73] [Cited by in F6Publishing: 75] [Article Influence: 7.3] [Reference Citation Analysis]
65 Weisheit S, Liebmann C. Allosteric modulation by protein kinase Cε leads to modified responses of EGF receptor towards tyrosine kinase inhibitors. Cell Signal 2012;24:422-34. [PMID: 21964064 DOI: 10.1016/j.cellsig.2011.09.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
66 Shen L, Park EJ, Kondratyuk TP, Guendisch D, Marler L, Pezzuto JM, Wright AD, Sun D. Design, synthesis, and biological evaluation of callophycin A and analogues as potential chemopreventive and anticancer agents. Bioorg Med Chem 2011;19:6182-95. [PMID: 21978950 DOI: 10.1016/j.bmc.2011.09.020] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
67 Chen P, Peng C, Pai H, Teng C, Chen C, Yang C. Denbinobin suppresses breast cancer metastasis through the inhibition of Src-mediated signaling pathways. The Journal of Nutritional Biochemistry 2011;22:732-40. [DOI: 10.1016/j.jnutbio.2010.06.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
68 Arora S, Bhardwaj A, Srivastava SK, Singh S, McClellan S, Wang B, Singh AP. Honokiol arrests cell cycle, induces apoptosis, and potentiates the cytotoxic effect of gemcitabine in human pancreatic cancer cells. PLoS One 2011;6:e21573. [PMID: 21720559 DOI: 10.1371/journal.pone.0021573] [Cited by in Crossref: 102] [Cited by in F6Publishing: 103] [Article Influence: 9.3] [Reference Citation Analysis]
69 Yan F, Li X, Jin Q, Jiang C, Zhang Z, Ling T, Qiu B, Zheng H. Therapeutic Ultrasonic Microbubbles Carrying Paclitaxel and LyP-1 Peptide: Preparation, Characterization and Application to Ultrasound-Assisted Chemotherapy in Breast Cancer Cells. Ultrasound in Medicine & Biology 2011;37:768-79. [DOI: 10.1016/j.ultrasmedbio.2011.02.006] [Cited by in Crossref: 59] [Cited by in F6Publishing: 63] [Article Influence: 5.4] [Reference Citation Analysis]
70 Lan K, Lan K, Sheu M, Chen M, Shih Y, Hsu F, Wang H, Liu R, Yen S. Honokiol inhibits hypoxia-inducible factor-1 pathway. International Journal of Radiation Biology 2011;87:579-90. [DOI: 10.3109/09553002.2011.568572] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
71 Kong L, Deng Z, Shen H, Zhang Y. Src family kinase inhibitor PP2 efficiently inhibits cervical cancer cell proliferation through down-regulating phospho-Src-Y416 and phospho-EGFR-Y1173. Mol Cell Biochem. 2011;348:11-19. [PMID: 21052789 DOI: 10.1007/s11010-010-0632-1] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 2.4] [Reference Citation Analysis]
72 Caccia D, Miccichè F, Cassinelli G, Mondellini P, Casalini P, Bongarzone I. Dasatinib reduces FAK phosphorylation increasing the effects of RPI-1 inhibition in a RET/PTC1-expressing cell line. Mol Cancer 2010;9:278. [PMID: 20955590 DOI: 10.1186/1476-4598-9-278] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 2.6] [Reference Citation Analysis]
73 Chien C, Chang S, Lin K, Chiu C, Chang L, Lin S. Taiwan cobra cardiotoxin III inhibits Src kinase leading to apoptosis and cell cycle arrest of oral squamous cell carcinoma Ca9-22 cells. Toxicon 2010;56:508-20. [DOI: 10.1016/j.toxicon.2010.05.007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
74 Chen Y, Wu C, Liu J, Fong Y, Hsu S, Li T, Su Y, Liu S, Tang C. Honokiol induces cell apoptosis in human chondrosarcoma cells through mitochondrial dysfunction and endoplasmic reticulum stress. Cancer Letters 2010;291:20-30. [DOI: 10.1016/j.canlet.2009.08.032] [Cited by in Crossref: 44] [Cited by in F6Publishing: 47] [Article Influence: 3.7] [Reference Citation Analysis]
75 Leeman-Neill RJ, Cai Q, Joyce SC, Thomas SM, Bhola NE, Neill DB, Arbiser JL, Grandis JR. Honokiol inhibits epidermal growth factor receptor signaling and enhances the antitumor effects of epidermal growth factor receptor inhibitors. Clin Cancer Res 2010;16:2571-9. [PMID: 20388852 DOI: 10.1158/1078-0432.CCR-10-0333] [Cited by in Crossref: 74] [Cited by in F6Publishing: 78] [Article Influence: 6.2] [Reference Citation Analysis]
76 Yuan Z, Liu H, Yan F, Wang Y, Gou L, Nie C, Ding Z, Lai S, Zhao Y, Zhao X, Li J, Deng H, Mao Y, Chen L, Wei Y, Zhao X. Improved therapeutic efficacy against murine carcinoma by combining honokiol with gene therapy of PNAS-4, a novel pro-apoptotic gene. Cancer Science 2009;100:1757-66. [DOI: 10.1111/j.1349-7006.2009.01242.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]